This report summarizes additional findings from a US-based national survey[1] investigating anti-Palestinian racism. The survey was conducted from March 1st through April 3rd, 2024 with approval from the University of California, San Francisco Institutional Review Board (IRB). The current analysis focuses on anti-Palestinian racism in the healthcare setting.
“Anti-Palestinian racism is a form of racism that “silences, excludes, erases, stereotypes, defames, or dehumanizes Palestinians or their narratives” and may be experienced by Palestinians and those perceived to be Palestinian as well as non-Palestinians who support Palestinian human or civil rights.[2]
This survey was designed in consultation with the Arab Canadian Lawyers Association and based on the description of anti-Palestinian racism delineated in their seminal report: “Anti-Palestinian Racism: Naming, Framing and Manifestations.”[3]
A 5-minute, voluntary national survey was developed based on information from the “Anti-Palestinian Racism: Naming, Framing and Manifestations” report, consultation with the Arab Canadian Lawyers Association, and consultation with pediatricians and other physicians, anti-racist and communication experts, educators, students, and community members. The survey was approved by the UCSF IRB prior to implementation. This survey utilized a voluntary convenience sample and was conducted online, distributed via email to multiple social media lists, physician groups, and other online lists. The results should not be interpreted as nationally representative.
The survey was developed to assess the impact of anti-Palestinian racism on both Palestinians and non-Palestinians. Findings reflect respondents’ self-reported experiences and should be interpreted accordingly.
Through our work as researchers, physicians, educators, and psychologists, we realized that anti-Palestinian racism affects both Palestinians and non-Palestinians. However, since anti-Palestinian racism is under-recognized and under-studied, many people are unaware of what they are experiencing. We hypothesized that anti-Palestinian racism impacts a larger and more diverse population than was previously understood, with potentially significant negative health impact. To our knowledge, this is the first national study designed to investigate this hypothesis.
Over 1200 respondents completed the survey. The majority of respondents identified as non-Palestinian (72.5%). The survey sample was racially and ethnically diverse, with self-reported race/ethnicity as follows: 35.8% Arab or Arab American, 32.0% White or European American, 22.7% Asian or Asian American, 7.3% Hispanic or Latinx, 6.9% multiracial or multiethnic, 3.7% Indigenous (including Indigenous American, Australasian, Alaskan, Arctic Indigenous, Native Hawaiian, Pacific Islander, and other Indigenous), and 3.6% Black or African American. Most respondents identified as women (61.0%) and non-Muslim (57.9%) including, but not limited to, Christian, Jewish, Buddhist and no religion. The sample was comprised of a diverse age range: 18–24 years (9.4%), 25–34 (28.6%), 35–44 (29.6%), 45–54 (17.8%), 55–64 (8.0%), 65–74 (5.2%), and 75+ (1.5%). In addition, 31.7% of respondents identified as LGBTQ+.
Summary of initial findings:
Full initial findings report can be viewed here.
This report is focused on the results from our survey regarding respondent exposure in U.S. healthcare setting.
Exposure was defined as experiencing and/or witnessing anti-Palestinian racism.
Patient exposure was defined as:
Healthcare provider exposure was defined as either:
A total of 1005 respondents reported exposure to anti-Palestinian racism. Of these, 216 (21.5%) reported exposure in the healthcare setting: 84 respondents (39%) reported exposure as a healthcare provider only (Provider Only), 74 (34%) as a healthcare provider and as a patient (Both Patient And Provider), and 58 (27%) reported exposure as a patient (Patient Only).
Adults aged 25-44, women, non-binary respondents, Muslims, Christians and those with no reported faith had the highest proportions of reported exposure in the healthcare setting (>= 20% for each category). Of respondents exposed to anti-Palestinian racism in the healthcare setting, 69% did not identify as Palestinian or Palestinian-American while 31% identified as Palestinian or Palestinian-American.
We examined the impact of exposure to anti-Palestinian racism on respondents’ physical and mental health. Severe health impact was defined as reports of respondents feeling their mental or physical health has been harmed (by personally experiencing or witnessing anti-Palestinian racism) most or all of the time. Options ranged from “I have not felt this at any time to I have felt or I feel this most or all of the time.”
Respondents were provided with examples of mental and physical health impacts. Mental health effects included anxiety, depression, difficulty concentrating, alienation, hyper-vigilance, and/or insomnia. Physical health effects included fatigue, headaches, loss of appetite, and/or body pain.
Severe health impact was reported by 60% of respondents exposed in the healthcare setting compared to 38% of respondents who were not exposed in the health care setting (p < 0.001). (Figure 1) When controlling for confounding variables (age, gender, faith, race, Palestinian identity and geographic region), respondents exposed in the healthcare setting had twice the odds of reporting severe health impact than those not exposed in the health care setting. (Figure 2)
The vast majority of respondents exposed to anti-Palestinian racism in a healthcare setting (91%) reported feeling isolated or alone in their concern for Palestinian human rights compared to 77% without exposure in healthcare settings (p < 0.001). (Figure 3) In addition, 73% of exposed respondents reported being afraid to speak out about what is happening to Palestinians in Gaza or for Palestinian human rights compared to 57% without exposure in healthcare settings (p < 0.001). (Figure 4)
Social harm was defined as experiencing silencing, exclusion, harassment, physical threat or harm, or defamation while advocating for Gaza and/or Palestinian human rights. Of all respondents exposed to anti-Palestinian racism, 81% of those exposed in the healthcare setting reported social harm, compared to 66% of those not exposed in a healthcare setting (p < 0.001). (Figure 5)
Of the 216 respondents who experienced anti-Palestinian racism in the healthcare setting, 84 (39%) reported exposure as Both Patient And Provider, 74 (34%) reported exposure as a Provider Only, and 58 (27%) reported exposure as a Patient Only.
Of respondents exposed in a healthcare setting, 76% of Patient Only reported severe health impact compared to 54% of all providers (Provider Only and Both Patient And Provider). (Figure 6) There was no statistically significant difference in severe health impact when comparing Provider Only to Both Patient And Provider.
The vast majority of respondents (91%) exposed in the healthcare setting reported feelings of isolation regardless of whether they were exposed as patients, providers or both. In addition, over 70% of exposed respondents reported feeling afraid and 90% of Patient Only respondents and 78% of all providers (Provider Only and Both Patient And Provider) exposed in a healthcare setting reported social harm. (Figure 7)
Importantly, Patient Only respondents had nearly three times the odds of reporting severe health impact than those with any exposure as providers (Provider Only and Both Patient And Provider), when controlling for age, gender, faith, race, Palestinian identity, and geographical region (adjusted odds ratio 2.81 (95% confidence intervals 1.29, 6.46)). (Figure 8)
Our findings show statistically significant associations between exposure to anti-Palestinian racism in healthcare settings and reported harms, including mental and physical health harms, among patients and providers across diverse demographic groups.
Patient Only respondents were particularly vulnerable to negative health impact, with a nearly threefold increase in the odds of severe harm to physical and/or mental health compared to those exposed as providers (Provider Only and Both Patient And Provider).
Importantly, respondents exposed to anti-Palestinian racism in the healthcare setting had twice the odds of reporting severe mental and/or physical harm, compared to those who were not exposed in the healthcare setting. In addition, respondents exposed to anti-Palestinian racism in the healthcare setting, reported statistically significant increases in isolation, fear and social harm compared to respondents not exposed in healthcare settings.
This survey utilized a voluntary online participation methodology and is not a representative national sample. Findings reflect respondents’ self-reported experiences and should be interpreted accordingly. We cannot make any inferences to a representative national population at this time. Nonetheless, the statistically significant associations observed warrant careful institutional review and merit further study.
In addition, the Joint Commission has clarified that racism and discrimination undermine patient safety. When anti-Palestinian racism produces harm or increases risk to patients, including delays in care, communication breakdowns, compromised informed consent, inequitable pain management, unsafe discharge, care avoidance, or patient-reported mental and physical health effects, including fear and isolation that obstruct safe communication and help-seeking, it creates conditions that increase risk of harm. Addressing these risks falls squarely within institutional quality and patient safety obligations.
Our analyses are consistent with extensive peer-reviewed literature documenting that exposure to discrimination and racism in healthcare settings results in heightened negative health outcomes.[4][5][6][7] Our findings raise serious patient safety concerns that warrant immediate institutional attention and intervention to assure the wellbeing and safety of our patients.
The following recommendations are grounded in established patient safety, health equity, accreditation, and civil-rights standards. They align with the Joint Commission’s National Patient Safety Goal to Improve Health Care Equity (NPSG.16.01.01) by integrating leadership accountability, assessment of barriers to care, disparity analysis, structured action planning, corrective intervention, and transparent stakeholder reporting. These recommendations apply existing quality and safety processes, including safety event review, Sentinel Event principles, trauma-informed care, and non-retaliation protections, to address documented harms associated with anti-Palestinian racism in healthcare settings as described in Anti-Palestinian Racism Survey: Patient Exposure Associated with Health Harm in US Healthcare Settings. In doing so, they operationalize current institutional responsibilities to ensure safe, equitable care for Palestinian patients, individuals perceived to be Palestinian, and non-Palestinian allies impacted by anti-Palestinian racism.
The organization will:
The organization will:
The organization will:
The organization will adopt and implement a written action plan that includes:
When anti-Palestinian racism affects care delivery or results in harm, the organization will:
The organization will:
IUAPR is a U.S.-based 501(c)(3) tax-exempt non-profit organization. Our interdisciplinary team is committed to empirically researching, educating and advocating on the impact of anti-Palestinian racism on individuals and communities across all sectors of society. IUAPR’s mission is to end racism against Palestinians and their allies including advocates for Palestinian rights and freedom.
If you would like to support our work, please donate here.